Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Relative Valuation - Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 29.83 CNY -0.7%

Market Cap: ¥9.4B

J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	CN

Multiples-Based Value

The Multiples-Based Value for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd (688076) under the Base Case is 44.65 CNY. Compared with the current market price of 29.83 CNY, the stock appears Undervalued by 33%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

Multiples-Based Value

Base Case

Undervaluation 33%

Multiples-Based Value

Price ¥29.83

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	9.4B CNY	5	18.9	18.5	18.5
US		Eli Lilly and Co NYSE:LLY	902.5B USD	13.8	43.7	29.5	31.5
US		Johnson & Johnson NYSE:JNJ	581.1B USD	6.2	21.7	15.1	18.5
UK		AstraZeneca PLC LSE:AZN	236.9B GBP	5.3	30.7	16.9	23.9
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.4	11.5	13
US		Merck & Co Inc NYSE:MRK	303.6B USD	4.7	16.6	10.3	12.5
CH		Novartis AG SIX:NOVN	232.5B CHF	5.2	20.9	12.9	16.6
IE	E	Endo International PLC LSE:0Y5F	244.4B USD	105.4	-83.6	386.8	970
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.4	10.3	7.7	9
US		Pfizer Inc NYSE:PFE	154.8B USD	2.5	19.9	7.7	10.2
US		Bristol-Myers Squibb Co NYSE:BMY	119.7B USD	2.5	17	7.2	8.8

				Revenue Growth	P/S to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average P/S: 14.4 5	35%	0.1
US		Eli Lilly and Co NYSE:LLY	13.8	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	7%	0.9
UK		AstraZeneca PLC LSE:AZN	5.3	N/A	N/A
CH		Roche Holding AG SIX:ROG	4.1	4%	1
US		Merck & Co Inc NYSE:MRK	4.7	5%	0.9
CH		Novartis AG SIX:NOVN	5.2	5%	1
IE	E	Endo International PLC LSE:0Y5F	105.4	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	1%	3.4
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average P/E: 21.9 18.9	37%	0.5
US		Eli Lilly and Co NYSE:LLY	43.7	32%	1.4
US		Johnson & Johnson NYSE:JNJ	21.7	7%	3.1
UK		AstraZeneca PLC LSE:AZN	30.7	26%	1.2
CH		Roche Holding AG SIX:ROG	19.4	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.6	14%	1.2
CH		Novartis AG SIX:NOVN	20.9	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -83.6	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.3	1%	10.3
US		Pfizer Inc NYSE:PFE	19.9	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	17	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average EV/EBITDA: 47.6 18.5	47%	0.4
US		Eli Lilly and Co NYSE:LLY	29.5	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15.1	2%	7.5
UK		AstraZeneca PLC LSE:AZN	16.9	13%	1.3
CH		Roche Holding AG SIX:ROG	11.5	6%	1.9
US		Merck & Co Inc NYSE:MRK	10.3	3%	3.4
CH		Novartis AG SIX:NOVN	12.9	5%	2.6
IE	E	Endo International PLC LSE:0Y5F	386.8	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.7	1%	7.7
US		Pfizer Inc NYSE:PFE	7.7	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.2	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average EV/EBIT: 102.9 18.5	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	31.5	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.5	6%	3.1
UK		AstraZeneca PLC LSE:AZN	23.9	21%	1.1
CH		Roche Holding AG SIX:ROG	13	6%	2.2
US		Merck & Co Inc NYSE:MRK	12.5	6%	2.1
CH		Novartis AG SIX:NOVN	16.6	9%	1.8
IE	E	Endo International PLC LSE:0Y5F	970	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9	2%	4.5
US		Pfizer Inc NYSE:PFE	10.2	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.8	-7%	N/A

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Competitors Multiples
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors